ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016
Resident Memory T Cells as Surrogate Markers of the Efficacy of Cancer Vaccines.
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Review
- Review
- The Emerging Role of Tissue-Resident Memory CD8Frontiers in oncology · 2021Review
- Tissue-resident lymphocytes: weaponized sentinels at barrier surfaces.F1000Research · 2020Review
- Tissue-Resident T Cells and Other Resident Leukocytes.Annual review of immunology · 2019Review
- Therapeutic cancer vaccine: building the future from lessons of the past.Seminars in immunopathology · 2019Review
- Resident memory T cells, critical components in tumor immunology.Journal for immunotherapy of cancer · 2018Review
- Tissue-resident memory T cells at the center of immunity to solid tumors.Nature immunology · 2018Review
- Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells.Journal of visualized experiments : JoVE · 2018Article
- The Emerging Role of CD8Frontiers in immunology · 2018Review
- Targeting Resident Memory T Cells for Cancer Immunotherapy.Frontiers in immunology · 2018Review
- Genealogy, Dendritic Cell Priming, and Differentiation of Tissue-Resident Memory CD8Frontiers in immunology · 2018Review
- Memory Inflation Drives Tissue-Resident Memory CD8Frontiers in immunology · 2018Article
- Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8Nature communications · 2017Article
- Induction of resident memory T cells enhances the efficacy of cancer vaccine.Nature communications · 2017Article
- Review
- Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours.Scientific reports · 2016Article
- Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer vaccine boost via the cervicovaginal rather than the intramuscular route of immunization appears to be crucial to induce genital CD8(+) T cells and tumor regression. This clinical activity is correlated with the ability of the mucosal boost to elicit resident memory T cells in the genital tract.
Indexed as
Identifiers
26542056What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.